Massachusetts medical device giant Boston Scientific (NYSE:BSX) today announced FDA approval for the latest in its line of coronary stents, the Rebel bare-metal stent.
Cardiovascular
Welcome to MassDevice's Cardiovascular Hub, your resource for the latest news in cardiac implants, structural heart, heart valves, stents and more. Stay informed about the innovations and business news shaping the cardiovascular device industry.
🫀 Narrow your focus with these categories:
Cardiac Implants | Structural Heart | Pulsed-Field Ablation
Here are top cardiology features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ LVADs save lives: So why aren’t more available?
+ How Medtronic uses nitinol to improve the structure and effectiveness of heart devices
+ How Abbott designed the world’s first dual-chamber leadless pacemaker system
+ J&J used RWE for expanded indications — and you can, too
+ 7 cardiology startups you need to know
Latest Cardiology News
Johnson & Johnson eyes acquisitions in cardiovascular, elsewhere
The world’s largest medical device operation is eyeing acquisitions to bolster its "subscale" cardiovascular business, particularly its electrophysiology business, Johnson & Johnson (NYSE:JNJ) chairman & CEO Alex Gorsky told analysts yesterday.
Press Release: Boston Scientific receives CE Mark for the new 25 mm Lotus valve system
Boston Scientific lands Euro approval for mid-size Lotus valve
Boston Scientific (NYSE:BSX) is heading straight to market with its 25 mm Lotus transcatheter aortic valve after winning CE Mark approval this week, the company announced.
Valve-in-valve surgery shows promise in new registry study
New research released this week provides more support for the use of transcatheter aortic valve-in-valve (VIV) implantation as a means of replacing previously implanted valves that have deteriorated over time.
More good news for Abbott’s MitraClip in JACC study
Back in the USA: Cook Medical’s Evolution lead extraction device returns
Cook Medical said today that it’s Evolution RL and Evolution Shortie RL cardiac lead extraction devices are back on the U.S. market after a 2-month suspension prompted by an FDA warning issued last April.
Ex-Medtronic exec Mackin is CryoLife’s new CEO
Cardiac Insight raises $7M
Cardiac Insight reported raising $7.1 million of a hoped-for $9.1 million round for its Stealth atrial fibrillation monitoring patch.
The equity round involved 2 unnamed investors, with the 1st sale coming June 26, according to a regulatory filing.
Silicon Valley in-depth: Unraveling arrhythmia with iRhythm CEO Kevin King
Digital health is all the rage in Silicon Valley, especially as consumer technology’s biggest players are getting more interested in tracking health and fitness. But for companies like iRhythm, the health side of the equation comes first.